IGF - Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cel

jeudi 26 décembre 2013

Related Articles Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway.



Pharm Biol. 2013 Dec 20;



Authors: Huang WJ, Bi LY, Li ZZ, Zhang X, Ye Y



Abstract

Abstract Context: Formononetin, an isoflavone, can inhibit the proliferation of cancer cells, including those of the prostate. However, its antitumor mechanism remains unclear. Aim: To investigate whether the insulin-like growth factor 1 (IGF-1)/insulin-like growth factor 1 receptor (IGF-1 R) signaling pathway mediates the formononetin antitumor effect on prostate cancer cells. Materials and methods: The viability of PC-3 cells was measured by MTT assay 48 h after formononetin treatment (25, 50 and 100 ?M). Formononetin-induced cell apoptosis was measured by Hoechst 33258 staining and flow cytometry. Expression of Bax mRNA was detected by real-time PCR, and the expression levels of Bax and IGF-1 R proteins were detected by western blots. Results: At concentrations >12.5 ?M, formononetin significantly inhibited the proliferation of human prostate cancer cells. Formononetin increased Bax mRNA and protein expression levels and decreased the expression levels of pIGF-1 R protein in a dose-dependent manner. Conclusion: High concentrations of formononetin-induced apoptosis in androgen-independent prostate cancer cells through inhibition of the IGF-1/IGF-1 R pathway.





PMID: 24359236 [PubMed - as supplied by publisher]







More...

Insulin like growth factors

IGF-1

Igf-1r3



This has been a World Class Bodybuilding automated thread




0 commentaires:

Enregistrer un commentaire

 

Lorem

Ipsum

Dolor